dc.contributor.author | 世界卫生大会, 60 | |
dc.coverage.spatial | 日内瓦 | en |
dc.date.accessioned | 2012-05-01T04:37:26Z | |
dc.date.available | 2012-05-01T04:37:26Z | |
dc.date.issued | 2007 | |
dc.identifier.govdoc | WHA60.16 | |
dc.identifier.uri | https://iris.who.int/handle/10665/26374 | |
dc.description | 第六十届世界卫生大会,议程项目12.17 | en |
dc.language.iso | zh | en |
dc.publisher | 世界卫生组织 | en |
dc.relation.uri | https://iris.who.int/handle/10665/26374 | |
dc.subject | Pharmaceutical products | en |
dc.subject | Resolutions and decisions | en |
dc.subject.mesh | Pharmaceutical Preparations | en |
dc.subject.mesh | Drug Utilization | en |
dc.subject.mesh | Drugs, Essential | en |
dc.subject.mesh | Drug Resistance, Microbial | en |
dc.subject.mesh | Information Systems | en |
dc.title | 药物的合理使用方面的进展 | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | administration and dosage | en |
who.relation.languageVersion | 10665/25841 | en |
who.relation.languageVersion | 10665/22589 | en |
who.relation.languageVersion | 10665/24104 | en |
who.relation.languageVersion | 10665/25899 | en |
who.relation.languageVersion | 10665/23621 | en |